Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

74.33
Delayed Data
As of Jun 24
 +0.39 / +0.53%
Today’s Change
67.88
Today|||52-Week Range
92.85
-11.78%
Year-to-Date
Incyte Gains on Jakafi's Breakthrough Status for Acute GVHD
Jun 24 / Zacks.com - Paid Partner Content
Diabetes Deep-Dive: What Investors Need to Know About This Devastating Disease
Jun 18 / MotleyFool.com - Paid Partner Content
Eli Lilly And (LLY) Marked As A Barbarian At The Gate
Jun 24 / TheStreet.com - Paid Partner Content
Better Buy: Johnson & Johnson vs. Eli Lilly
Jun 15 / MotleyFool.com - Paid Partner Content
Sanofi's Likely Sweetener for Medivation Panned
Jun 23 / TheStreet.com - Paid Partner Content
Merck's Biosimilar Version of Lantus Tops Phase III Studies
Jun 14 / Zacks.com - Paid Partner Content
How Big Is the Diabetes Treatment Market?
Jun 22 / MotleyFool.com - Paid Partner Content
Price of cancer drugs vastly higher in US, according to study
Jun 06 / FT.com - Paid Partner Content
This New Class Of Medicine Could Reshape Diabetes Treatment
Jun 20 / MotleyFool.com - Paid Partner Content